Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8224580 Optimization of crossover points for directed evolution

Patent 8224580 was granted and assigned to Codexis on July, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Codexis
Codexis
0
Date Filed
June 12, 2007
0
Date of Patent
July 17, 2012
0
Patent Application Number
11818237
0
Patent Citations Received
‌
US Patent 12129495 Engineered DNA polymerase variants
0
‌
US Patent 12012620 Peroxidase activity towards 10-acetyl-3,7-dihydroxyphenoxazine
0
‌
US Patent 12012618 Engineered galactose oxidase variant enzymes
0
‌
US Patent 12018295 Engineered DNA polymerase variants
0
‌
US Patent 12071642 Engineered amylase variants
0
‌
US Patent 12110493 Engineered purine nucleoside phosphorylase variant enzymes
0
‌
US Patent 12110521 Engineered methionine gamma lyase variants
0
‌
US Patent 12110513 Engineered pantothenate kinase variant enzymes
0
‌
US Patent 11746369 Ketoreductase polypeptides and polynucleotides
‌
US Patent 11760981 Engineered glycosyltransferases and steviol glycoside glucosylation methods
•••
Patent Inventor Names
Claes Gustafsson
0
Jeremy S. Minshull
0
Sridhar Govindarajan
0
Emily C. Mundorff
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8224580
0
Patent Primary Examiner
‌
Marjorie Moran
0

Find more entities like US Patent 8224580 Optimization of crossover points for directed evolution

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo